Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial

Table 4

The multivariable linear regression analysis for assessing predictors of mRS.

Variable			95% CI	value
Group	Placebo group	Reference
	ALC group	-1.18	-0.52, -1.84	0.001
Gender	Female	Reference
	Male	0.38	-0.17, 1.14	0.20
Coronary artery diseases	No	Reference
	Yes	0.65	-0.12, 1.42	0.098
mRS before		0.87	0.49, 1.27	<0.001

Note: ALC = acetyl-L-carnitine. Adjusted for other variables in the model. The significant value is shown in bold type.